Tirzepatide—the active ingredient in Mounjaro—is a first-in-class dual-incretin medication that targets both GLP-1 and GIP receptors. While many people recognize Tirzepatide for its exceptional ability to reduce A1C and support weight loss, one mechanism often overlooked is its effect on glucagon secretion. Glucagon is a key hormone in blood sugar regulation, working as the...